Yehudit Bergman, MS

Johns Hopkins
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 314 - Ceftazidime-Avibactam Versus Meropenem-Vaborbactam for the Treatment of Carbapenem-Resistant Enterobacterales Infections

  Friday, October 18, 2024
  11:18 AM – 11:30 AM US PT